Creative Commons Attribution-Share Alike 4.0
Hat mitgewirkt an:
-
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
-
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
-
Projekt Lightspeed : der Weg zum BioNTech-Impfstoff - und zu einer Medizin von morgen
-
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes